• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Successful reduction of NAPPA score (Nail Assessment in Psoriasis and Psoriasis-Arthritis) under secukinumab in severe nail psoriasis].

作者信息

Alhumam Aminah

机构信息

Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Deutschland.

Department of Dermatology, College of Medicine King Faisal University, Al-Ahsa, Saudi-Arabien.

出版信息

Dermatologie (Heidelb). 2024 Feb;75(2):149-152. doi: 10.1007/s00105-023-05235-1. Epub 2023 Oct 12.

DOI:10.1007/s00105-023-05235-1
PMID:37823915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10824815/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ee/10824815/b394038b073f/105_2023_5235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ee/10824815/c5b99830e6c0/105_2023_5235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ee/10824815/b394038b073f/105_2023_5235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ee/10824815/c5b99830e6c0/105_2023_5235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ee/10824815/b394038b073f/105_2023_5235_Fig2_HTML.jpg

相似文献

1
[Successful reduction of NAPPA score (Nail Assessment in Psoriasis and Psoriasis-Arthritis) under secukinumab in severe nail psoriasis].[司库奇尤单抗治疗重度甲银屑病时成功降低银屑病和银屑病关节炎的甲评估（NAPPA）评分]
Dermatologie (Heidelb). 2024 Feb;75(2):149-152. doi: 10.1007/s00105-023-05235-1. Epub 2023 Oct 12.
2
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.司库奇尤单抗治疗指甲银屑病的临床疗效和疾病负担的影响：随机安慰剂对照 TRANSFIGURE 试验的 32 周结果。
Br J Dermatol. 2019 Nov;181(5):954-966. doi: 10.1111/bjd.17351. Epub 2019 Jan 16.
3
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.司库奇尤单抗治疗指甲银屑病疗效高且持久：来自银屑病关节炎患者 III 期试验的事后分析。
Br J Dermatol. 2022 Sep;187(3):438-441. doi: 10.1111/bjd.21233. Epub 2022 Jun 7.
4
Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis.在一名儿科患者中使用司库奇尤单抗可显著改善指甲银屑病和银屑病关节炎。
Pediatr Dermatol. 2019 May;36(3):384-385. doi: 10.1111/pde.13767. Epub 2019 Feb 27.
5
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.司库奇尤单抗在指甲银屑病中显示出高且持续的疗效：随机安慰剂对照TRANSFIGURE研究的2.5年结果
Br J Dermatol. 2021 Mar;184(3):425-436. doi: 10.1111/bjd.19262. Epub 2020 Dec 16.
6
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study.司库奇尤单抗可显著改善合并甲损害患者的指甲银屑病、银屑病关节炎的体征和症状及放射学进展：III 期 FUTURE 5 研究 2 年结果。
Clin Exp Rheumatol. 2022 May;40(5):952-959. doi: 10.55563/clinexprheumatol/3nuz51. Epub 2021 Sep 3.
7
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.银屑病和银屑病关节炎的甲病评估（NAPPA）：一种评估甲银屑病结局的工具的制定和验证。
Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664.
8
Comparative microscopic analysis of nail clippings from patients with cutaneous psoriasis and psoriatic arthritis.对皮肤银屑病和银屑病关节炎患者指甲剪屑的比较显微镜分析。
An Bras Dermatol. 2017 Jan-Feb;92(1):21-25. doi: 10.1590/abd1806-4841.20175056.
9
Ultrasonographic and power doppler parameters of nails fail to differentiate between onychodystrophy in patients with psoriasis vulgaris or psoriatic arthritis.超声和彩色多普勒参数无法区分寻常型银屑病或银屑病关节炎患者的甲营养不良。
Adv Rheumatol. 2024 Apr 11;64(1):25. doi: 10.1186/s42358-024-00367-x.
10
Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.司库奇尤单抗成功治疗红皮病型银屑病和银屑病关节炎并伴有严重非感染性葡萄膜炎：一例报告
J Int Med Res. 2020 Nov;48(11):300060520969494. doi: 10.1177/0300060520969494.

本文引用的文献

1
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis.指甲受累作为中度至重度银屑病患者中苏金单抗与优特克单抗不同治疗效果的预测指标
Dermatol Ther (Heidelb). 2022 Jan;12(1):233-241. doi: 10.1007/s13555-021-00654-1. Epub 2021 Dec 6.
2
Efficacy of Systemic Treatments of Nail Psoriasis: A Systemic Literature Review and Meta-Analysis.甲银屑病全身治疗的疗效：一项系统文献综述与荟萃分析。
Front Med (Lausanne). 2021 Feb 10;8:620562. doi: 10.3389/fmed.2021.620562. eCollection 2021.
3
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
网络荟萃分析比较生物制剂治疗实现指甲银屑病完全缓解的疗效。
J Dermatolog Treat. 2022 May;33(3):1652-1660. doi: 10.1080/09546634.2021.1892024. Epub 2021 Mar 1.
4
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.司库奇尤单抗在指甲银屑病中显示出高且持续的疗效：随机安慰剂对照TRANSFIGURE研究的2.5年结果
Br J Dermatol. 2021 Mar;184(3):425-436. doi: 10.1111/bjd.19262. Epub 2020 Dec 16.
5
The impact of fingernail psoriasis on patients' health-related and disease-specific quality of life.指甲银屑病对患者健康相关及疾病特异性生活质量的影响。
Dermatology. 2014;229(2):76-82. doi: 10.1159/000360696. Epub 2014 Aug 27.
6
Scoring nail psoriasis.甲银屑病评分。
J Am Acad Dermatol. 2014 Jun;70(6):1061-6. doi: 10.1016/j.jaad.2014.02.010. Epub 2014 Mar 31.
7
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.银屑病和银屑病关节炎的甲病评估（NAPPA）：一种评估甲银屑病结局的工具的制定和验证。
Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664.
8
Interventions for nail psoriasis.指甲银屑病的干预措施。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD007633. doi: 10.1002/14651858.CD007633.pub2.
9
[Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy].[甲银屑病——一种被忽视的疾病。发病机制、诊断与治疗]
Hautarzt. 2012 Mar;63(3):184-91. doi: 10.1007/s00105-011-2228-4.
10
Methods of outcomes measurement in nail psoriasis.甲银屑病的结局测量方法。
Dermatology. 2010;221 Suppl 1:23-8. doi: 10.1159/000316177. Epub 2010 Aug 9.